13F

Stock

Crispr Therapeutics Ag

CRSP · held by 3 managers

Reported value

$21.3M

Holders

3

+0 new · −0 exited

Holders’ est. mark

$5.82M

Price effect on 3 books still in the name

Largest holder

$19.6M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC313K$19.6M$5.39MCut−$3.6M
Norris Financial Group, LLC14.9K$930.7K$248.7KAdded$274.8K
Marex Group plc13.1K$818K$183.8KAdded$333.3K

Positions as of Q4 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.